Correction: Discontinuation of non-Vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a population-based cohort study using primary care data from The Health Improvement Network in the UK
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
BMJ Publishing Group
2020-04-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/4/e031342corr1.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK
by: Mar Martín-Pérez, et al.
Published: (2019-09-01) -
Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation
by: Stanojković Zoran, et al.
Published: (2020-01-01) -
Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
by: Craig I. Coleman, et al.
Published: (2019-01-01) -
Clinical Outcomes of Non Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Non Valvular Atrial Fibrillation Patients: A Cohort Study in a Rural Tertiary Care Hospital, Gujarat, India
by: Sohilkhan Riyazkhan Pathan, et al.
Published: (2025-07-01) -
Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01)